Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash provided by operating activities | 128,436 | 127,837 |
| Investing activities | ||
| Acquisition of Azstarys (net of cash acquired) | (655,403) | — |
| Purchases of property and equipment | (766) | (863) |
| Purchases of marketable securities | (20,100) | (42,501) |
| Sales of marketable securities | 151,805 | — |
| Maturities of marketable securities | 23,500 | 30,769 |
| Net cash used in investing activities | (500,964) | (12,595) |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s capex?
- Collegium Pharmaceutical, Inc. (COLL) reported capex of $496K in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s capex changed year-over-year?
- Collegium Pharmaceutical, Inc.'s capex increased by 663.1% year-over-year, from $65K to $496K.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s capex?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s capex has grown at a -2.7% compound annual growth rate (CAGR), from $1.94M to $1.74M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Collegium Pharmaceutical, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude